APC Responds to Lawmakers’ Concerns Over Marketing of Compounded Medications
Lawmakers have raised concerns with the FDA regarding Hims & Hers recent Super Bowl ad and its implications for compounded medication marketing. APC CEO Scott Brunner responds with a detailed statement, emphasizing the regulatory distinctions between compounded drugs and FDA-approved pharmaceuticals, the role of the FTC in oversight, and APC’s commitment to best practices in marketing transparency. Read the full statement to stay informed on this evolving discussion.
On Thursday, February 20, APC is hosting a webinar that will provide an in-depth look at best practices for ethically marketing compounding services and products while adhering to regulatory requirements. Register today to learn more about what is and is not allowed in marketing compounded medications.